 |
   
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Press Release Approval of Fulyzaq (Crofelemer) to Relieve Symptoms of Diarrhea in HIV/AIDS Patients Taking Antiretroviral TherapyJanuary 2, 2013 On December 31, 2012, FDA approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking combination antiretroviral therapy. The recommended dose is one 125 mg delayed-release tablet taken orally two times a day, with or without food. Fulyzaq tablets should not be crushed or chewed. Tablets should be swallowed whole. Diarrhea is experienced by many HIV/AIDS patients and is a common reason why patients discontinue or switch their antiretroviral therapies. Fulyzaq is indicated in HIV/AIDS patients whose diarrhea is not caused by an infection from a virus, bacteria, or parasite. Patients take Fulyzaq two times a day to manage watery diarrhea due to the secretion of electrolytes and water in the gastrointestinal tract. View Full Article Visit the FDA's website to find out more about their activities and publications.
Comment by: Samuel
(London, UK.)
Sat., Jan. 5, 2013 at 10:28 am EST Wow! This could change my life. I've suffered from diarrhoea since I began treatment 7 years ago. The thing though is that I'm not "watery", just "frequent" and "mushy"! So I wonder if that would qualify me for this drug, or whether it would be better for me to take an immodium tablet every day? Body.com, could we have one of your experts discuss this, please, in a future article? Thanks.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before adding your comment, please read TheBody.com's Comment Policy.) |
 |
Email
Comments
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
